AV
A. Volkovreader
4hBookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
ApoB is causally related to atherosclerotic cardiovascular disease and lowering it lowers events lifelong.
Every adult should have Lp(a) measured once because it is genetically determined and modifies CVD risk.
The frequency of statin-induced muscle symptoms is dramatically overstated outside of nocebo conditions.
A CAC score of zero at age 50 confers a 10-year ASCVD risk under 2% regardless of LDL.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.